Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
Peking University People's Hospital
Peking University People's Hospital
Melbourne Health
Shenzhen Geno-Immune Medical Institute
National Cancer Institute (NCI)